Summary of Eric Verdin presentation at End Age-Related Diseases 2021
Live Forever Club - 21-Aug-2021Discusses causes and prevention of NAD depletion with a focus on CD38 consumption
Join the club for FREE to access the whole archive and other member benefits.
Hear the latest developments from the leading experts in rejuvenation biotechnology research
19-Aug-2021 to 22-Aug-2021
This year, we are looking at the rejuvenation biotechnology industry as an ecosystem. We will be trying to identify the gaps in coordination and collaboration that can be filled by a concerted effort of the life extension community. We will be also paying special attention to the burden of neurodegenerative diseases along with innovative approaches to maintaining mental health and rejuvenating the aging brain.
In addition to bringing together the thought leaders of the rejuvenation biotechnology industry to foster scientific and business collaborations, we will provide interviews and panel discussions on related topics, such as the philosophy of life extension, the ethics of longevity journalism, and the relationship between rejuvenation biotechnology and blockchain technology. The conference will help you to deepen your understanding of what is going on in the aging research field.
The speakers at this conference are:
• Allison Duettmann
• Aubrey de Grey
• Eric Verdin
• Greg Fahy
• Ilmira Gilmutdinova
• Irina Conboy
• Jacob Kimmer
• Jay Sarkar
• Joao Pedro de Megalhaes
• Keith Comito
• Lorna Harries
• Michael Greve
• Michael Lustgarten
• Michael Snyder
• Oliver Medvedik
• Peter Fedichev
• Reason
• Sergey Young
• Steve Horvath
• Tobias Reichmuth
• Tyler Golato
• Vadim Gladyshev
Visit website: https://www.lifespan.io/ending-age-related-diseases-2021-conference/
See also: Lifespan.io (LEAF) - Supporting the development of biotechnologies focused on ending age-related diseases
Details last updated 27-May-2021
Interested in more events? View the club's event calendar.
World expert in organ cryopreservation, Chief Scientific Officer and Co-founder at Intervene Immune
Professor of Molecular Biogerontology at University of Birmingham Institute of Inflammation and Ageing, consultant, futurist, speaker
Director of The Maurice Kanbar Center for Biomedical Research and Vice President of LEAF.
Scientist at Stanford University, Co-Founder and Head Of Research at Turn Biotechnologies
Discusses causes and prevention of NAD depletion with a focus on CD38 consumption
Very much looking forward to seeing published results on initial human pilot